These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23315862)

  • 1. Influence of the human MIF promoter polymorphism on hepatocellular carcinoma prognosis.
    Yuan T; Tang C; Chen M; Deng S; Chen P
    Genet Mol Res; 2013 Jan; 12(4):6629-35. PubMed ID: 23315862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the relationship between human MIF level, MIF-794CATT5-8 microsatellite polymorphism, and susceptibility of tuberculosis in Southwest China.
    Li Y; Zeng Z; Deng S
    Braz J Infect Dis; 2012; 16(4):383-6. PubMed ID: 22846129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage migration inhibitory factor promoter polymorphisms (-794CATT
    Wu S; Sun J; Lian J; Shang H; Tao H; Xie J; Lin W
    J Obstet Gynaecol Res; 2017 Mar; 43(3):571-579. PubMed ID: 28160516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CATT polymorphism in MIF gene promoter is closely related to human pulmonary tuberculosis in a southwestern China population.
    Liu A; Bao F; Voravuthikunchai SP
    Int J Immunopathol Pharmacol; 2018; 32():2058738418777108. PubMed ID: 29809055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of the vascular endothelial growth factor and the macrophage migration inhibitory factor in the progression of hepatocellular carcinoma.
    Wang D; Luo L; Chen W; Chen LZ; Zeng WT; Li W; Huang XH
    Oncol Rep; 2014 Mar; 31(3):1199-204. PubMed ID: 24366206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.
    Wang B; Xia CY; Lau WY; Lu XY; Dong H; Yu WL; Jin GZ; Cong WM; Wu MC
    J Am Coll Surg; 2013 Dec; 217(6):1054-62. PubMed ID: 24246620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis.
    Wirtz TH; Fischer P; Backhaus C; Bergmann I; Brandt EF; Heinrichs D; Koenen MT; Schneider KM; Eggermann T; Kurth I; Stoppe C; Bernhagen J; Bruns T; Fischer J; Berg T; Trautwein C; Berres ML
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31370326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between MIF gene polymorphisms and carotid artery atherosclerosis.
    Lan MY; Chang YY; Chen WH; Tseng YL; Lin HS; Lai SL; Liu JS
    Biochem Biophys Res Commun; 2013 May; 435(2):319-22. PubMed ID: 23537651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
    Wu J; Chen F; Zhang X; Li Y; Ma H; Zhou Y; Jin Y; Wang H; Bai J; Zhang G; Fu S
    J Dermatol Sci; 2009 Mar; 53(3):212-5. PubMed ID: 19157791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.
    Nakanishi K; Sakamoto M; Yamasaki S; Todo S; Hirohashi S
    Cancer; 2005 Jan; 103(2):307-12. PubMed ID: 15593087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric cancer susceptibility in gastric cancer relatives: attributable risks of Macrophage migration inhibitory factor promoter polymorphism and Helicobacter pylori.
    Li H; Zang J; Wang P; Dai L; Zhang J; Wang K
    Cytokine; 2012 Nov; 60(2):346-51. PubMed ID: 22892326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Hira E; Ono T; Dhar DK; El-Assal ON; Hishikawa Y; Yamanoi A; Nagasue N
    Cancer; 2005 Feb; 103(3):588-98. PubMed ID: 15612021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B; Liu W; Wang L; Li M; Wang J; Huang L; Huang P; Yuan Y
    Ann Surg Oncol; 2010 Jul; 17(7):1917-26. PubMed ID: 20112070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of plasma macrophage migration inhibitory factor for diagnosis and prognosis of hepatocellular carcinoma.
    Zhao YM; Wang L; Dai Z; Wang DD; Hei ZY; Zhang N; Fu XT; Wang XL; Zhang SC; Qin LX; Tang ZY; Zhou J; Fan J
    Int J Cancer; 2011 Nov; 129(10):2463-72. PubMed ID: 21213214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma.
    Chen TY; Li YC; Liu YF; Tsai CM; Hsieh YH; Lin CW; Yang SF; Weng CJ
    Ann Surg Oncol; 2011 Aug; 18(8):2348-56. PubMed ID: 21298348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis.
    Baugh JA; Chitnis S; Donnelly SC; Monteiro J; Lin X; Plant BJ; Wolfe F; Gregersen PK; Bucala R
    Genes Immun; 2002 May; 3(3):170-6. PubMed ID: 12070782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
    Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
    Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea.
    Kim JS; Choi J; Hahn HJ; Lee YB; Yu DS; Kim JW
    PLoS One; 2016; 11(9):e0162477. PubMed ID: 27598332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.